Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in PLoS Biol Retrieve available abstracts of 23 articles: HTML format

Single Articles

June 2025
1. YIN X, Pu Y, Yuan S, Pache L, et al
   Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.
   PLoS Biol. 2025;23:e3002738.
   PubMed     Abstract available
   
   
   April 2025
2. GILBERT SC
   Priorities for rapid and cost-effective vaccines to improve outbreak responses.
   PLoS Biol. 2025;23:e3003114.
   PubMed     Abstract available
   
   
   
3. KUBINSKI HC, Despres HW, Johnson BA, Schmidt MM, et al
   Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
   PLoS Biol. 2025;23:e3003115.
   PubMed     Abstract available
   
   
   January 2025
4. MEARS HV, Young GR, Sanderson T, Harvey R, et al
   Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
   PLoS Biol. 2025;23:e3002982.
   PubMed     Abstract available
   
   
   December 2024
5. KUCHARSKI AJ
   Controlling minor outbreaks is necessary to prepare for major pandemics.
   PLoS Biol. 2024;22:e3002945.
   PubMed     Abstract available
   
   
   November 2024
6. DADONAITE B, Ahn JJ, Ort JT, Yu J, et al
   Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance.
   PLoS Biol. 2024;22:e3002916.
   PubMed     Abstract available
   
   
   
7. HAY JA, Zhu H, Jiang CQ, Kwok KO, et al
   Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course.
   PLoS Biol. 2024;22:e3002864.
   PubMed     Abstract available
   
   
   September 2024
8. LE PEN J, Paniccia G, Kinast V, Moncada-Velez M, et al
   A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.
   PLoS Biol. 2024;22:e3002767.
   PubMed     Abstract available
   
   
   March 2024
9. BEKDASH R, Yoshida K, Nair MS, Qiu L, et al
   Developing inhibitory peptides against SARS-CoV-2 envelope protein.
   PLoS Biol. 2024;22:e3002522.
   PubMed     Abstract available
   
   
   January 2024
10. RUSSELL TW, Townsley H, Abbott S, Hellewell J, et al
    Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    PLoS Biol. 2024;22:e3002463.
    PubMed     Abstract available
    
    
    December 2023
11. SIMMONS HC, Watanabe A, Oguin Iii TH, Van Itallie ES, et al
    A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
    PLoS Biol. 2023;21:e3002415.
    PubMed     Abstract available
    
    
    November 2023
12. VALE-COSTA S, Etibor TA, Bras D, Sousa AL, et al
    ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions.
    PLoS Biol. 2023;21:e3002290.
    PubMed     Abstract available
    
    
    
13. ZHU Z, Fan H, Fodor E
    Defining the minimal components of the influenza A virus replication machinery via an in vitro reconstitution system.
    PLoS Biol. 2023;21:e3002370.
    PubMed     Abstract available
    
    
    
14. KALIMUDDIN S, Ooi EE
    Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics.
    PLoS Biol. 2023;21:e3002351.
    PubMed     Abstract available
    
    
    
15. LYTRAS S, Wickenhagen A, Sugrue E, Stewart DG, et al
    Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
    PLoS Biol. 2023;21:e3002398.
    PubMed     Abstract available
    
    
    August 2023
16. LADNER JT, Sahl JW
    Towards a post-pandemic future for global pathogen genome sequencing.
    PLoS Biol. 2023;21:e3002225.
    PubMed     Abstract available
    
    
    
17. LOBINSKA G, Pilpel Y, Nowak MA
    Evolutionary safety of lethal mutagenesis driven by antiviral treatment.
    PLoS Biol. 2023;21:e3002214.
    PubMed     Abstract available
    
    
    
18. KRAFT TS, Seabright E, Alami S, Jenness SM, et al
    Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
    PLoS Biol. 2023;21:e3002108.
    PubMed     Abstract available
    
    
    July 2023
19. OLAJIDE OM, Osman MK, Robert J, Kessler S, et al
    Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.
    PLoS Biol. 2023;21:e3002182.
    PubMed     Abstract available
    
    
    June 2023
20. STRINE MS, Cai WL, Wei J, Alfajaro MM, et al
    DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
    PLoS Biol. 2023;21:e3002097.
    PubMed     Abstract available
    
    
    
21. CHEN NFG, Chaguza C, Gagne L, Doucette M, et al
    Development of an amplicon-based sequencing approach in response to the global emergence of mpox.
    PLoS Biol. 2023;21:e3002151.
    PubMed     Abstract available
    
    
    
22. TSU BV, Agarwal R, Gokhale NS, Kulsuptrakul J, et al
    Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome.
    PLoS Biol. 2023;21:e3002144.
    PubMed     Abstract available
    
    
    May 2023
23. EALES O, Haw D, Wang H, Atchison C, et al
    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
    PLoS Biol. 2023;21:e3002118.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.